Moderna has said it is filing for regulatory approval in the US, and that its vaccine trials have shown no serious safety concerns.The US-based company has also said its vaccine was 94.1% effective,
U.S. biotech company Moderna plans to begin its final phase of testing for its COVID-19 vaccine on July 27, according to details posted Tuesday on government database
U.S. biotech firm Moderna said on Thursday it expects to begin a phase-3 study of its COVID-19 vaccine candidate in July. Moderna has finalized the phase-3 study proto
简体中文
